1.. STANDARDS: Facility related
. Large inventory of disposable supplies for vascular access management, cervico-cerebral angiography, carotid intervention with embolic protection, and intra-cranial thrombus retrieval devices.
1.2. 4 . Emergency management equipment and systems must be readily available in the interventional location performing carotid stenting. This includes resuscitation and personel familiar with their indications and use.
1.2. 5 . There must be a process documenting routine preventive maintenance and testing of laboratory equipment, including a comprehensive radiation safety program such as outlined by The Society for Cardiovascular Angiography and Interventions . Rather than an inclusive document, this is to serve as a topic summary with recommendations for best practice. This will provide a framework for evaluating current compliance with these recommendations. Over time, these standards may become requirements for accreditation. 
2.. STANDARDS: Personnel related

2.2.2.
The institution must have a defined process for recredentialing which should be based on volume, outcomes, fulfillment of CME requirements and other quality parameters.
There are currently no accepted standards for recredentialing. These may develop over time and be implemented in a later version of these standards.
2.2.3.
Recertification criteria for individual practitioners should be decided by each institution but guidelines should include documentation for fulfillment of CME requirements as outlined in 2.2.1 and participation in at least 75 % of M and M and/or case review meetings.
2.2.4.
The operator's complications should not exceed delineated thresholds.
2.2.5.
Hospital privileges and state licensing should be maintained throughout the period of certification for all operators. Any loss of either hospital privileges or state license shall be reported to ACE with an explanation from the Medical Director.
Other Health Care Professionals
2.3.1.
Skilled allied health professionals in the laboratory (nurses and technicians) must be trained and experienced in evaluating patients before and after catheter-based interventional procedure. State requirements for performance and roles of personnel must be supplied and facilities will be reviewed for compliance based on these standards. 
2.4.
There must be a process in place for providing acute neuro-rescue or stroke intervention in the event of a complication. Documentation of this policy must be provided. 
3.. STANDARDS: Quality assurance
3.5.
The oversight committee should be empowered to identify the minimum case volume for primary operators to maintain privileges, as well as a threshold complication rate to trigger suspension of privileges or activation of measures for remediation 3.6 . Major events such as Death & , Major Stroke rate should not exceed 3% for asymptomatic and should not exceed 6% for symptomatic patients. 4 . 5 . ≥90% of determinations should meet these criteria for stenosis depending on symptomatic status. Failure to achieve a minimum of 75% compliance with stenosis severity will result in remedial action less than 75% compliance with stenosis severity may result in denial of accreditation.
4.. STANDARDS Patient: Indications
4.6.
All treated patients shall have a post procedure cerebral angiogram to evaluate flow and evaluate for distal embolization 4.6.1. Pre treatment cerebral anatomy may be evaluated by DSA but if so documentation of these findings should be included as part of the pre procedure evaluation. Otherwise, pre stenting cerebral angiography should be performed as part of the initial angiographic lesion and anatomic assessment.
4.7.
High surgical risk (CMS criteria) vs. average surgical risk 4.7.1. Patients at high risk for CEA are defined as having significant comorbidities and/or anatomic risk factors(i.e.,recurrent stenosis and/or previous radical neck dissection), and would be poor candidates for CEA. Significant comorbid conditiona include but are not limited to: (Services, 2010)
• Congestive Heart Failure (CHF) class III/IV
• Left ventricular ejection fraction (LVEF)<30%
• Unstable Angina
• Contralateral caroted occlusion
• Recent myocardial infarction (MI)
• Prior radiation treamtnet to the neck
• Other conditions that were used to determine patients at high risk for CEA in the prior carotid artery stenting trials and studies such as ARCHER, CABERNET, SAPPHIRE, BEACH, MAVERIC II 
